Funded Tech Companies

AN2 Therapeutics

Wondering who invested in AN2 Therapeutics? BVF Partners, Avidity Partners and Hatteras Venture Partners joined the equity holders in this biopharmaceutical company.

Company Overview

Contact Information

Company Background Information

Overview

AN2 Therapeutics, Inc. is a California-based global health biopharmaceutical company focused on bringing the power of modern biomedical and drug development expertise to provide transformational medicines for patients suffering from infectious diseases.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

1/7/2022

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Eric Easom

        

Chief Financial Officer

Lucy Day

        

Chief Financial Officer

Paul Eckburg

        

Co-Founder

Michael Alley

        

Vice President

Vince Hernandez

        

VP - Bus. Development

Sanjay Chanda

        

VP - Manufacturing

Kieron Wesson

        

VP - Operations

Kevin Krause

        

Company Investors

• BVF Partners
• Avidity Partners
• Hatteras Venture Partners
• RA Capital
• Monashee Investment Management
• Surveyor Capital
• Brii Biosciences
• BioRock Ventures
• Mountain Group Capital (Robert Readnour)
• Adjuvant Capital

Browse more funded tech companies:

An Estuary | ANA Therapeutics

Share this article

About Our Venture Capital Database

This tech company profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary